International Journal of Microbiology
Volume 2021 (2021), Article ID 7356890, 1 page
https://doi.org/10.1155/2021/7356890

Corrigendum

Corrigendum to “Clinical Trials of Probiotic Strains in Selected Disease Entities”

Ruth Dudek-Wicher, Adam Junka, Justyna Paleczny, and Marzenna Bartoszewicz

Department of Pharmaceutical Microbiology and Parasitology, Faculty of Pharmacy, Medical University of Silesian Piasts, Wrocław, Poland

Correspondence should be addressed to Ruth Dudek-Wicher; r.dudek.wicher@gmail.com

Received 2 February 2021; Accepted 2 February 2021; Published 12 February 2021

Copyright © 2021 Ruth Dudek-Wicher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Clinical Trials of Probiotic Strains in Selected Disease Entities” [1], the funding information in the Acknowledgments section should be corrected as follows:

This publication was prepared under the project financed from the funds granted by the Ministry of Science and Higher Education in the “Regional Initiative of Excellence” Programme for the years 2019–2022, project number 016/RID/2018/19, and the amount of funding is 11,998,121.30 PLN.

References

R. Dudek-Wicher, A. Junka, J. Paleczny, and M. Bartoszewicz, “Clinical trials of probiotic strains in selected disease entities,” International Journal of Microbiology, vol. 2020, Article ID 8854119, 8 pages, 2020.